NEW YORK, April 2 – Pharmacopeia announced that it has merged its software subsidiaries into a new unit named Accelrys, which will begin operating as a separate unit on June 1.

The four subsidiaries, Molecular Simulations, Synopsys Scientific Systems, Oxford Molecular, and the Genetics Computer Group, had pro forma revenues of more than $90 million in 2000, or 76 percent of Pharmacopeia’s overall revenues of $119 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.